Precision BioSciences Announces Receipt of FDA Fast Track De

Precision BioSciences Announces Receipt of FDA Fast Track Designation for ECUR-506, iECURE's Program for the Treatment of Neonatal Onset Ornithine Transcarbamylase (OTC) Deficiency

Precision BioSciences Announces Receipt of FDA Fast Track Designation for ECUR-506, iECURE's Program for the Treatment of Neonatal Onset Ornithine Transcarbamylase (OTC) Deficiency

marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.

Related Keywords

United Kingdom , United States , Australia , Michael Amoroso , Jamesm Wilson , University Of Pennsylvania Gene Therapy Program , Linkedin , Nasdaq , Drug Administration , European Commission , Precision Biosciences Inc , Precision Biosciences , Fast Track , Ornithine Transcarbamylase , Rare Pediatric Disease , Orphan Drug , Chief Executive Officer , Gene Therapy Program , Private Securities Litigation Reform Act , Annual Report ,